| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | -19.3% | -45.3% |
| Cost of Revenue | $1.3M | -20.6% | -50.4% |
| Gross Profit | $1.1M | -17.5% | -37.4% |
| R&D Expense | $667K | -3.9% | -27.0% |
| SG&A Expense | $1.8M | +6.8% | -8.8% |
| Operating Income | -$3.1M | +3.0% | +11.6% |
| Pre-tax Income | -$3.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | +123.4% | +267.1% |
| Accounts Receivable | $1.9M | -17.9% | -57.5% |
| Current Assets | $4.5M | +19.6% | -20.1% |
| Total Assets | $8.7M | +2.8% | -30.8% |
| Current Liabilities | $9.6M | -22.1% | +18.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.8M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $923K | — | — |
| Financing Cash Flow | $5.6M | — | — |
| Free Cash Flow | -$6.8M | — | — |
| -28.0% |
| +1.9% |
| Income Tax | $0 | — | — |
| Net Income | -$3.6M | -28.0% | +1.9% |
| EPS (Basic) | $3.25 | +171.9% | +701.9% |
| EPS (Diluted) | -$2.65 | — | +87.7% |
| $10.7M |
| -14.9% |
| +18.2% |
| Stockholders' Equity | -$2.0M | +51.3% | -157.0% |